Status:
COMPLETED
Epidemiology of Anaerobic Bacteria in Cystic Fibrosis Patients: Descriptive and Non-interventional Study
Lead Sponsor:
University Hospital, Brest
Collaborating Sponsors:
Vaincre la Mucoviscidose
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
Brief Summary
Recently, the respiratory microbiota characterisation of a Cystic Fibrosis (CF) patients' cohort has highlighted the potential role of anaerobes, and specially species belonging to the genus Porphyrom...
Detailed Description
Cystic Fibrosis (CF) is a lethal genetic disease whose prognostic depends on the patients' respiratory impairment. Indeed, the airways microbial chronic colonization, particularly to Pseudomonas aerug...
Eligibility Criteria
Inclusion
- Patients with a confirmed diagnosis of Cystic Fibrosis regardless of CFTR genotype
- Persons affiliated to the social security system
- Minor or major patients able to expectorate spontaneously or after induction
- Consent signed by the patient or the holder of parental authority for the children
Exclusion
- Persons deprived of liberty, persons under guardianship or curatorship, persons in emergency situations
- Persons non affiliated to a social security system or not entitled
- Pulmonary transplant patients
- Refusal to participate to the study
Key Trial Info
Start Date :
March 29 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 5 2018
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT04879381
Start Date
March 29 2018
End Date
October 5 2018
Last Update
June 30 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU de Brest
Brest, France, 29609
2
Fondation Ildys
Roscoff, France, 29250